Steward Partners Investment Advisory’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.06K | Buy |
+537
| New | +$5.9K | ﹤0.01% | 3790 |
|
|
2025
Q3 | – | Sell |
-22
| Closed | -$270 | – | 4314 |
|
|
2025
Q2 | $270 | Sell |
22
-2
| -8% | -$29 | ﹤0.01% | 4013 |
|
|
2025
Q1 | $528 | Hold |
24
| – | – | ﹤0.01% | 3854 |
|
|
2024
Q4 | $544 | Sell |
24
-61
| -72% | -$1.33K | ﹤0.01% | 3838 |
|
|
2024
Q3 | $1.54K | Buy |
85
+16
| +23% | +$371 | ﹤0.01% | 3477 |
|
|
2024
Q2 | $2.01K | Sell |
69
-261
| -79% | -$7.74K | ﹤0.01% | 3284 |
|
|
2024
Q1 | $11.7K | Hold |
330
| – | – | ﹤0.01% | 2753 |
|
|
2023
Q4 | $14.4K | Hold |
330
| – | – | ﹤0.01% | 2551 |
|
|
2023
Q3 | $12.6K | Hold |
330
| – | – | ﹤0.01% | 2501 |
|
|
2023
Q2 | $13.6K | Sell |
330
-47
| -12% | -$2.26K | ﹤0.01% | 2467 |
|
|
2023
Q1 | $21.6K | Hold |
377
| – | – | ﹤0.01% | 2216 |
|
|
2022
Q4 | $21.1K | Hold |
377
| – | – | ﹤0.01% | 2212 |
|
|
2022
Q3 | $16K | Hold |
377
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q2 | $20K | Sell |
377
-330
| -47% | -$19.8K | ﹤0.01% | 2221 |
|
|
2022
Q1 | $45K | Buy |
707
+300
| +74% | +$19.8K | ﹤0.01% | 1970 |
|
|
2021
Q4 | $27K | Hold |
407
| – | – | ﹤0.01% | 2194 |
|
|
2021
Q3 | $28K | Hold |
407
| – | – | ﹤0.01% | 2171 |
|
|
2021
Q2 | $28K | Hold |
407
| – | – | ﹤0.01% | 4382 |
|
|
2021
Q1 | $28.1K | Hold |
407
| – | – | ﹤0.01% | 2300 |
|
|
2020
Q4 | $26K | Hold |
407
| – | – | ﹤0.01% | 1964 |
|
|
2020
Q3 | $19K | Hold |
407
| – | – | ﹤0.01% | 1910 |
|
|
2020
Q2 | $19K | Hold |
407
| – | – | ﹤0.01% | 1789 |
|
|
2020
Q1 | $18K | Sell |
407
-28
| -6% | -$1.47K | ﹤0.01% | 1645 |
|
|
2019
Q4 | $25K | Sell |
435
-44
| -9% | -$2.62K | ﹤0.01% | 1702 |
|
|
2019
Q3 | $28K | Hold |
479
| – | – | ﹤0.01% | 1605 |
|
|
2019
Q2 | $26K | Buy |
+479
| New | +$24.7K | ﹤0.01% | 1600 |
|
|
2018
Q4 | – | Sell |
-479
| Closed | -$32K | – | 1389 |
|
|
2018
Q3 | $32K | Buy |
479
+119
| +33% | +$7.39K | ﹤0.01% | 1361 |
|
|
2018
Q2 | $23K | Hold |
360
| – | – | ﹤0.01% | 1409 |
|
|
2018
Q1 | $19K | Hold |
360
| – | – | ﹤0.01% | 1349 |
|
|
2017
Q4 | $17K | Buy |
360
+30
| +9% | +$1.47K | ﹤0.01% | 1182 |
|
|
2017
Q3 | $16K | Hold |
330
| – | – | ﹤0.01% | 999 |
|
|
2017
Q2 | $17K | Hold |
330
| – | – | ﹤0.01% | 911 |
|
|
2017
Q1 | $13K | Hold |
330
| – | – | ﹤0.01% | 868 |
|
|
2016
Q4 | $14K | Buy |
+330
| New | +$13.4K | 0.01% | 500 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Steward Partners Investment Advisory's IART Position: Q1 2026 in Review
Steward Partners Investment Advisory opened a new position in Integra LifeSciences (IART) in Q1 2026: 537 shares worth $5.06K. The stake represents ﹤0.01% of the portfolio and ranks #3790 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in IART as recently as Q2 2025.
Steward Partners Investment Advisory first reported a position in IART in Q4 2016 and has held it in 34 quarters since. The position peaked at $45K in Q1 2022. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Steward Partners Investment Advisory held 537 shares of Integra LifeSciences worth $5.06K as of Q1 2026.
- Integra LifeSciences was a new Steward Partners Investment Advisory position in Q1 2026.
- Integra LifeSciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3790 holding.
- Steward Partners Investment Advisory first reported a position in Integra LifeSciences in Q4 2016 and has held it in 34 quarters since.
- Steward Partners Investment Advisory's Integra LifeSciences position peaked at $45K in Q1 2022.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.